Pharmaceutical discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) within open-house procedures
IKK classic, DresdenTED 426545-2026
value not stated32 lots
Fri 5 May23:59 in Berlin
555days
Medical supplies contracts in Germany
118 open tenders
Email me new onesCountryTenderValueClosesDays left
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8, SGB V via an Open-House model for the active substance Icatibant (WHO ATC code: B06AC02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 174735-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
581days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8, SGB V via an Open-House model for the active substance Calcipotriol/Betamethasone - Foam (official ATC code: D05AX22)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 213144-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
581days
Conclusion of non-exclusive agreements on pharmaceuticals containing the active substance roxadustat (ATC Code: B03XA05) under an open-house model
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 216077-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
581days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8, SGB V via an Open-House model for the active substance Calcipotriol/Betamethasone - Cream (official ATC code: D05AX22)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 207477-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
581days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8, SGB V via an Open-House model for the active substance Interferon beta-1b (WHO ATC code: L03AB08)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 176917-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
581days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 SGB V under an open-house model for the active substance octreotide (WHO ATC Code: H01CB02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 214696-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
581days
Non-exclusive drug discount agreement conclusion pursuant to § 130a para. 8 SGB V via an open-house model for the active ingredient Golimumab (ATC code according to WHO: L04AB06)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 721873-2026
value not stated1 lot
Fri 30 Jun23:58 in Berlin
611days
Conclusion of a non-exclusive medicinal product discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) under an Open-House model for the active substance raltegravir 600 mg (WHO ATC Code: J05AJ01).
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 236436-2026
value not stated1 lot
Fri 30 Jun23:58 in Berlin
611days
Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to Section 130a Paragraph 8 of the Fifth Book of the German Social Code (SGB V) under an open-house model for the active substance Etanercept (WHO ATC Code: L04AB01)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 705586-2026
value not stated1 lot
Fri 30 Jun23:58 in Berlin
611days
Conclusion of non-exclusive discount agreements for pharmaceuticals under § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Raltegravir 400 mg (WHO ATC code: J05AJ01)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 238743-2026
value not stated1 lot
Fri 30 Jun23:58 in Berlin
611days
Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to Section 130a Paragraph 8 of the Fifth Book of the German Social Code (SGB V) under an open-house model for the active substance Adalimumab (WHO ATC Code: L04AB04)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 705314-2026
value not stated1 lot
Fri 30 Jun23:58 in Berlin
611days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to Section 130a Paragraph 8 of Book V of the Social Code (SGB V) via an open-house model for the active substance certolizumab pegol (WHO ATC Code: L04AB05).
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 728085-2026
value not stated1 lot
Fri 30 Jun23:59 in Berlin
611days
Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 of Book V of the Social Code (SGB V) under an Open-House model for the active substance infliximab for subcutaneous injection (WHO ATC Code: L04AB02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 745901-2026
value not stated1 lot
Fri 30 Jun23:59 in Berlin
611days
Drug discount contracts pursuant to § 130a, paragraph 8 of the Social Code Book V (SGB V) within the framework of Open-House procedures
IKK classic, DresdenTED 599075-2026
value not stated24 lots
Wed 5 Jul23:59 in Berlin
616days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Lanthanum(III) carbonate in the dosage form chewable tablets
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 344198-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
642days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Peginterferon beta-1a (WHO ATC Code: L03AB13)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 343454-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
642days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Somatropin (WHO ATC Code: H01AC01)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 345458-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
642days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V by way of an open-house model for the active ingredient Perindopril/Amlodipine/Indapamide (ATC code according to WHO: C09BX01)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 735158-2026
value not stated1 lot
Mon 31 Jul23:59 in Berlin
642days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V by way of an open-house model for the active ingredient Tocilizumab (ATC code according to WHO: L04AC07)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 748225-2026
value not stated1 lot
Mon 31 Jul23:59 in Berlin
642days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.